Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Eiji Takeuchi
Kensuke Kondo
Yoshio Okano
Michihiro Kunishige
Yoshihiro Kondo
Naoki Kadota
Hisanori Machida
Nobuo Hatakeyama
Keishi Naruse
Hirokazu Ogino
Hiroshi Nokihara
Tsutomu Shinohara
Yasuhiko Nishioka
机构：
[1] National Hospital Organization Kochi Hospital,Department of Clinical Investigation
[2] Tokushima University,Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences
[3] National Hospital Organization Kochi Hospital,Department of Respiratory Medicine
[4] National Hospital Organization Kochi Hospital,Department of Pathology
[5] Tokushima University,Department of Community Medicine for Respirology, Graduate School of Biomedical Sciences
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Early death; Early mortality factors; Immune checkpoint inhibitors; Lung cancer; Monotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3139 / 3147
页数：8
相关论文
共 50 条
  • [31] Immune checkpoint inhibitor for advanced or recurrent non-small cell lung cancer patients with poor performance status
    Koyama, Junji
    Kimura, Tomoki
    Oi, Hajime
    Yamano, Yasuhiko
    Yokoyama, Toshiki
    Matsuda, Toshiaki
    Kataoka, Kensuke
    Matsuzawa, Reiko
    Fukihara, Jun
    Sakamoto, Koji
    Morise, Masahiro
    Hashimoto, Naozumi
    Kondoh, Yasuhiro
    Hasegawa, Yoshinori
    ANNALS OF ONCOLOGY, 2019, 30 : 141 - 141
  • [32] Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study
    Jia Feng
    Xinyi Chen
    Jiayan Wei
    Yiming Weng
    Jingsong Wang
    Tong Wang
    Qibin Song
    Peng Min
    Scientific Reports, 14
  • [33] Is checkpoint inhibitor pneumonitis underreported in patients with advanced non-small cell lung cancer (NSCLC) on PD-1 inhibitor monotherapy?
    Spieler, Benjamin Oren
    Lopes, Gilberto
    Dal Pra, Alan
    Diwanji, Tejan
    Yechieli, Raphael
    Freedman, Laura M.
    Mihaylov, Ivaylo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer
    Kuo, Chih-Hsi Scott
    Wang, Chin-Chou
    Huang, Yu-Chen
    Pavlidis, Stelios
    Liu, Chien-Ying
    Ko, How-Wen
    Chung, Fu-Tsai
    Lin, Tin-Yu
    Wang, Chih-Liang
    Guo, Yi-Ke
    Yang, Cheng-Ta
    THORACIC CANCER, 2019, 10 (05) : 1158 - 1166
  • [35] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    LUNG CANCER, 2023, 183
  • [36] PATIENT EXPERIENCE OF IMMUNE CHECKPOINT INHIBITOR THERAPY FOR NON-SMALL CELL LUNG CANCER
    Williams, Loretta A.
    Whisenant, Meagan
    Malveaux, Donna
    Singhi, Eric K.
    Altan, Mehmet
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [37] Avelumab: another active immune checkpoint inhibitor in non-small cell lung cancer
    Xie, Hao
    Adjei, Alex A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 : S41 - S43
  • [38] The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer
    Watanabe, Hiromi
    Kubo, Toshio
    Ninomiya, Kiichiro
    Kudo, Kenichiro
    Minami, Daisuke
    Murakami, Etsuko
    Ochi, Nobuaki
    Ninomiya, Takashi
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Ohashi, Kadoaki
    Fujiwara, Keiichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (08) : 762 - 765
  • [39] Factors Predicting for Early Mortality in Non-Small Cell Lung Cancer
    Amini, A.
    Glaser, S. M.
    Akhavan, D.
    Li, R.
    Nelson, R.
    Stokes, W. A.
    Koczywas, M.
    Reckamp, K. L.
    Salgia, R.
    Gaspar, L. E.
    Kavanagh, B. D.
    Rusthoven, C. G., Jr.
    Liu, A. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E670 - E671
  • [40] Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer
    Minami, Seigo
    Ihara, Shouichi
    Tanaka, Tsunehiro
    Komuta, Kiyoshi
    WORLD JOURNAL OF ONCOLOGY, 2020, 11 (01) : 9 - 22
12345